Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2019 Dec 1;117(6):S243-S254.
doi: 10.5546/aap.2019.S243.

[Guideline for diagnosis and treatment of immune thrombocytopenia]

[Article in Spanish]
National Hematology Committee, Sociedad Argentina de Pediatría; Hugo Donato  1 , Viviana Bacciedoni  2 , María Cristina Rapetti  2 , Graciela Elena  2 , Marta Lavergne  2 , Néstor Rossi  2 , Alejandra Cedola  2 , Rodrigo Parias Nucci  2
Affiliations
Free article
Practice Guideline

[Guideline for diagnosis and treatment of immune thrombocytopenia]

[Article in Spanish]
National Hematology Committee, Sociedad Argentina de Pediatría et al. Arch Argent Pediatr. .
Free article

Abstract

Management, outcome, diagnosis, prognosis and treatment of immune thrombocytopenia are controversial. Several guidelines stating different experts' opinions have been published; however, no worldwide consensus regarding the management of the disease has still been reached. This guideline defines diagnostic criteria, states initial laboratory tests, establishes differential diagnosis, develops topics concerning outcome and prognosis, and enumerates available treatments for acute and chronic disease, as well as for management of life-threatening bleeding.

Keywords: idiopathic thrombocytopenic purpura; immune thrombocytopenia; pediatrics; treatment.

Plain language summary

El manejo de la trombocitopenia inmune es motivo de discusión en lo concerniente a evolución, diagnóstico, pronóstico y tratamiento. Se han publicado varias guías que expresan distintas opiniones de expertos, pero no existe aún consenso mundial sobre cuál es el manejo más adecuado de la enfermedad. Esta guía establece los criterios para definir el diagnóstico; detalla el plan de estudios de laboratorio por realizar inicialmente; plantea los distintos diagnósticos diferenciales; desarrolla aspectos relativos a evolución y pronóstico, y enumera los tratamientos disponibles para las formas agudas y las crónicas, así como para el manejo de las emergencias y en algunas situaciones especiales.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009; 113:(11)2386-93.
    1. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009; 113(26):6511-21.
    1. Stasi R. Immune thrombocytopenia: pathophysiologic and clinical update. Semin Thromb Hemost. 2012; 38(5):454-62.
    1. Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia. Presse Med. 2014; 43(4 Pt 2):e49-59.
    1. Audia S, Mahévas M, Samson M, Godeau B, et al. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017; 16(6):620-32.

Publication types

MeSH terms

LinkOut - more resources